InsiderClue
Stocks · Health care · Services-Commercial Physical & Biological Research

MAXCYTE, INC.

MXCT Clue Score24
United States Fiscal year ends December CIK 0001287098
$1.01 -0.98% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.01 −90.33% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 5 Dec 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue13.3Operating income−12.4Net income−12.9EPS, diluted−0.23Fiscal year 2020Revenue15.5 +16.6%Operating income−11.1Net income−11.8EPS, diluted−0.17Fiscal year 2021Revenue21.6 +39.6%Operating income−18.2Net income−19.1EPS, diluted−0.21Fiscal year 2022Revenue28.7 +33.3%Operating income−27.4Net income−23.6EPS, diluted−0.23Fiscal year 2023Revenue19.5 −32.2%Operating income−48.3Net income−37.9EPS, diluted−0.37Fiscal year 2024Revenue22.2 +13.9%Operating income−51.2Net income−41.1EPS, diluted−0.39Fiscal year 2025Revenue21.0 −5.7%Operating income−51.9Net income−44.6EPS, diluted−0.42
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 13.3 15.5 21.6 28.7 19.5 22.2 21.0
Growth +16.6% +39.6% +33.3% −32.2% +13.9% −5.7%
Operating income −12.4 −11.1 −18.2 −27.4 −48.3 −51.2 −51.9
Net income −12.9 −11.8 −19.1 −23.6 −37.9 −41.1 −44.6
Growth
EPS, diluted −0.23 −0.17 −0.21 −0.23 −0.37 −0.39 −0.42
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin144.2%Operating margin−93.7%Net margin−97.3%Free cash flow margin−76.0%Fiscal year 2020Gross margin151.5%Operating margin−71.6%Net margin−76.5%Free cash flow margin−70.2%Fiscal year 2021Gross margin140.2%Operating margin−84.3%Net margin−88.5%Free cash flow margin−67.3%Fiscal year 2022Gross margin136.2%Operating margin−95.2%Net margin−82.0%Free cash flow margin−115.7%Fiscal year 2023Gross margin187.4%Operating margin−247.7%Net margin−194.5%Free cash flow margin−130.2%Fiscal year 2024Gross margin141.9%Operating margin−230.5%Net margin−184.8%Free cash flow margin−131.7%Fiscal year 2025Gross margin127.9%Operating margin−247.6%Net margin−213.0%Free cash flow margin−172.6%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 144.2% 151.5% 140.2% 136.2% 187.4% 141.9% 127.9%
Operating margin −93.7% −71.6% −84.3% −95.2% −247.7% −230.5% −247.6%
Net margin −97.3% −76.5% −88.5% −82.0% −194.5% −184.8% −213.0%
Free cash flow margin −76.0% −70.2% −67.3% −115.7% −130.2% −131.7% −172.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−8.8Capital expenditure−1.3Free cash flow−10.1Fiscal year 2020Operating cash flow−8.8Capital expenditure−2.1Free cash flow−10.9Fiscal year 2021Operating cash flow−10.7Capital expenditure−3.8Free cash flow−14.5Fiscal year 2022Operating cash flow−14.8Capital expenditure−18.5Free cash flow−33.3Fiscal year 2023Operating cash flow−21.7Capital expenditure−3.7Free cash flow−25.4Fiscal year 2024Operating cash flow−27.6Capital expenditure−1.7Free cash flow−29.3Fiscal year 2025Operating cash flow−34.4Capital expenditure−1.8Free cash flow−36.2
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −8.8 −8.8 −10.7 −14.8 −21.7 −27.6 −34.4
Capital expenditure −1.3 −2.1 −3.8 −18.5 −3.7 −1.7 −1.8
Free cash flow −10.1 −10.9 −14.5 −33.3 −25.4 −29.3 −36.2
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash15.2Shareholders’ equity13.6Fiscal year 2020Cash18.8Shareholders’ equity33.2Fiscal year 2021Cash47.8Shareholders’ equity262.9Fiscal year 2022Cash11.1Shareholders’ equity254.0Fiscal year 2023Cash46.5Shareholders’ equity232.2Fiscal year 2024Cash27.9Shareholders’ equity206.3Fiscal year 2025Cash20.1Shareholders’ equity171.5
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 15.2 18.8 47.8 11.1 46.5 27.9 20.1
Shareholders’ equity 13.6 33.2 262.9 254.0 232.2 206.3 171.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
13.3 15.5 21.6 28.7 19.5 22.2 21.0
Growth +16.6% +39.6% +33.3% −32.2% +13.9% −5.7%
2.5 2.8 3.6 5.1 4.7 7.1 6.2
19.1 23.4 30.2 39.2 36.5 31.5 26.8
Growth +22.4% +29.2% +29.5% −6.7% −13.7% −15.0%
17.6 17.7 15.4 19.5 23.8 22.2 20.8
5.6 7.4 18.7 25.8 30.1 29.7 28.1
−12.4 −11.1 −18.2 −27.4 −48.3 −51.2 −51.9
Growth
n/a n/a n/a n/a −37.9 −41.1 −44.6
0.0 0.0 0.0 n/a n/a n/a n/a
−12.9 −11.8 −19.1 −23.6 −37.9 −41.1 −44.6
Growth
Per share
−0.23 −0.17 −0.21 −0.23 −0.37 −0.39 −0.42
−0.23 −0.17 −0.21 −0.23 −0.37 −0.39 −0.42
Growth
56.4 69.5 90.6 101.7 103.3 104.8 106.4
56.4 69.5 90.6 101.7 103.3 104.8 106.4
Growth +23.2% +30.5% +12.2% +1.5% +1.5% +1.5%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 6.3% a year over five years.
  • The diluted share count rose 53.2% in five years, which is dilution.
  • Operating margin is down 176.1 points on five years ago, at -247.6%.
  • A net loss in 7 of 7 years on file.